Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Non-Current Debt (2021 - 2025)

Historic Non-Current Debt for ProQR Therapeutics (PRQR) over the last 3 years, with Q4 2023 value amounting to $4.6 million.

  • ProQR Therapeutics' Non-Current Debt rose 597.73% to $4.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $4.6 million, marking a year-over-year increase of 597.73%. This contributed to the annual value of $4.6 million for FY2023, which is 654.64% up from last year.
  • As of Q4 2023, ProQR Therapeutics' Non-Current Debt stood at $4.6 million, which was up 597.73% from $4.4 million recorded in Q4 2022.
  • ProQR Therapeutics' 5-year Non-Current Debt high stood at $45.0 million for Q4 2021, and its period low was $4.4 million during Q4 2022.
  • Its 3-year average for Non-Current Debt is $18.0 million, with a median of $4.6 million in 2023.
  • As far as peak fluctuations go, ProQR Therapeutics' Non-Current Debt crashed by 9031.24% in 2022, and later soared by 597.73% in 2023.
  • ProQR Therapeutics' Non-Current Debt (Quarter) stood at $45.0 million in 2021, then crashed by 90.31% to $4.4 million in 2022, then grew by 5.98% to $4.6 million in 2023.
  • Its Non-Current Debt stands at $4.6 million for Q4 2023, versus $4.4 million for Q4 2022 and $45.0 million for Q4 2021.